What does the HRR 29 Gene Panel (Germline) at Metropolis Healthcare include?
It analyzes 29 HRR-related genes to detect inherited variants linked to hereditary cancer risk.
How does Metropolis Healthcare perform this germline gene panel?
Metropolis Healthcare uses high-depth NGS and robust bioinformatics to accurately identify pathogenic and likely pathogenic variants.
Who should consider taking this test at Metropolis Healthcare?
Individuals with a personal or family history of breast, ovarian, prostate, or related cancers should consider this panel.
Is fasting required for this germline genetic test at Metropolis Healthcare?
No fasting is needed; a blood sample (EDTA) is typically used for analysis.
How long do results take at Metropolis Healthcare?
Results usually take 2–3 weeks due to detailed sequencing and variant interpretation.
Can this test at Metropolis Healthcare help in early cancer risk detection?
Yes, identifying germline HRR mutations can guide surveillance, prevention, and risk-reduction strategies.
How accurate is germline NGS analysis at Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy through deep sequencing coverage and stringent quality checks.
Does this test support personalized treatment planning at Metropolis Healthcare?
Yes, HRR gene findings can guide targeted therapies such as PARP inhibitors in certain cancers.